PATENT CLAIM ANALYSIS

Application Number: 16242897
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["800", "278000"]

Abstract:
The inventive technology relates to systems and methods for enhanced in vivo production, accumulation and modification of cannabinoids. In one embodiment, the invention may include systems and methods for enhanced in vivo biosynthesis of chemically-modified water-soluble cannabinoids in a whole plant, or a cell suspension culture system.

Claim (Index 190):
An in vivo method of for high level production and accumulation of water-soluble cannabinoids comprising the steps of:\n genetically modify a cannabinoid producing plant or cell thereof to disrupt or knock out expression of one or more endogenous cannabinoid synthase genes; genetically modify said cannabinoid producing plant or cell thereof to express:\n a nucleotide sequence encoding at least one cytosolic directed cannabinoid synthase having the trichome targeting sequence disrupted or removed; and \n a nucleotide sequence encoding at least one heterologous glycosyltransferase having glycosylation activity towards at least one cannabinoid.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 99.0
- Lexical Diversity: 1.40541
- Patent Class: 800.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['16110728', '14232465', '14510232', '15321585', '13641272']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.586683968593331
- 35 USC 102 Novelty (BERT): 0.7446027378263499
- Combined Prediction Score: 0.6024758455166329
- Mean Citation Score: 487.126922
- Max Citation Score: 935.623
- Similarity Product: 849.4564488992693

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test